Consumer Product Safety Improvement Act.
The Consumer Product Safety Improvement Act of 2008 (CPSIA) requires manufacturers and importers of certain consumer products (including certain drug products) manufactured on or after November 12, 2008, to certify that their products comply with all applicable rules, bans, standards, or regulations enforced by the Consumer Product Safety Commission (CPSC). Under the CPSIA, manufacturers and importers must make available to customers a certificate specifying that the product complies with the applicable CPSC rule, ban, standard, or regulation. Such certification must be based on a test of each product or upon a reasonable testing program.
Sensipar® is sold in special child-resistant packaging that must meet the requirements of the Poison Prevention Packaging Act. Accordingly, Amgen furnishes below links to the General Conformity Certificates for the product identified by corresponding finished drug product lot number
2008 General Conformity Certificates identified by corresponding finished drug product lot number.
2009 General Conformity Certificates identified by corresponding finished drug product lot number.
30 mg. |
|
60 mg. |
|
90 mg. |
|
Sample |
|
2010 General Conformity Certificates identified by corresponding finished drug product lot number.
For questions, please call Amgen Medical Information 1-800-77AMGEN
